Mr. Thomas Eriksson , 44
Co-Founder, Chief Exec. Officer, Director and Chief Exec. Officer of Neonode Technologies AB 366.00K 2.35M............................shareholders should demand yachts$
They won't survive without a suitor. They sell a lot of soda but make no money (same for Kombucha). The K ramp of about a few years ago is non-existent. You can't grow the brand without unit price increase and brand recognition. Without a large marketing arm around the R brand K its an unknown. Expect a sell out for sure at bargain price.
Yes- Reed's will be acquired. CR isn't motivated or, to take the company to a level of importance. Therefore, I too see a "I give up and a sell out"". How can you compete with GT- if you cut advertisement. The brand itself is unknown. I don't see Reed's pushing out Kombucha to the masses on their own. Sales are very nominal after introduction into channel. Great products under a different company and leadership.
I must admit NP you are funny- me, i get all my beer preferences from print ads. i think most people do. Smart spend- go CR and give away stock on Facebook to boost stock price and consumer awareness in product.
Absolutely, it ridiculous to enter stock in a contest (not sure if its illegal SEC rules). Another day of trying to roll in the grass that's above eyesight.
Three years in waiting for a turnaround. Local Sprouts- out of supply (chronic problems- when will they ever end)
Put in a program that stops spammers like helpisland website
GET YOUR ACTS TOGETHER- RID SPAM!
Piper Jaffray Keeps @ Overweight; Ups Tgt to $58 vs $51
Should trials continue to pan out for company, this stock will be GOOGLE size like giant in biotech.
Excellent analysis- Hobby business vs running an efficient operation and prepared to be the best in all facets. After sitting around for a couple of years, I've witnessed chronic rookie operational errors and inflated promises, all accounts running into the next ones. Ask yourself, do you scratch your head after every cc and say not again? Then, you might be most forgiving to a business fault line, for holding onto a company which disappoints its shareholders. Now traders, love the ups/downs. At some point one needs to stop fighting reality and stop rationalizing and thus, clouding common sense investment judgment.
Great management- 1 little Indian.
I guess were #$%$ stock price is what it was at IPO And investors have made no money in holding the stock in a bull market all around, And CR screws up every quarter. SO- your back in congrats.
Worth reading up on$
If beta-thal trial expands to larger patient population with success continued (proven in x-transfusions), then expect this stock to grow like a Google, except in Biotech. GOTMILKGOTPEDRO$
The lead sales for Reed's in my opinion is the whole company, as he is a stand up citizen. Let's pray he doesn't push his boat off to distant shores under the accentuation of screwing up vs running a business.
As a whole the Komb category needs market power Your never by word of mouth (some Facebook likes or other media similar) going to lift a brand to stardom. My suggestion would be to take Komb to the soda platform (vs CSD's) and introduce it as what's good for you and makes health sense. The only thing holding the stock up is a infinitude takeover mention (asset sale promise). And we've seen every promise evaporate, or get mucked on the launch pad, transport, plant or any other excuse. They better make numbers or the stock will be $3 dollars. EOM